These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38548267)

  • 1. Poorly Differentiated Hepatocellular Carcinoma Cells Avoid Apoptosis by Interacting with T Cells via CD40-CD40 Ligand Linkage.
    Vinh Hanh N; Thi Thanh Thuy L; Ngoc Hieu V; Hai H; Ikenaga H; Sato-Matsubara M; Uchida-Kobayashi S; Urushima H; Van Khanh N; Thi Ha N; Shinkawa H; Kubo S; Ohtani N; Enomoto M; Tamori A; Kawada N
    Am J Pathol; 2024 Jul; 194(7):1230-1247. PubMed ID: 38548267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
    Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
    Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of functional CD40 in human hepatocellular carcinoma.
    Sugimoto K; Shiraki K; Ito T; Fujikawa K; Takase K; Tameda Y; Moriyama M; Nakano T
    Hepatology; 1999 Oct; 30(4):920-6. PubMed ID: 10498643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of ex vivo peripheral and intrahepatic α-fetoprotein-specific CD4+ responses in hepatocellular carcinoma.
    Witkowski M; Spangenberg HC; Neumann-Haefelin C; Büttner N; Breous E; Kersting N; Drognitz O; Hopt UT; Blum HE; Semmo N; Thimme R
    Int J Cancer; 2011 Nov; 129(9):2171-82. PubMed ID: 21170957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells.
    Yuzugullu H; Benhaj K; Ozturk N; Senturk S; Celik E; Toylu A; Tasdemir N; Yilmaz M; Erdal E; Akcali KC; Atabey N; Ozturk M
    Mol Cancer; 2009 Oct; 8():90. PubMed ID: 19849855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence.
    Kamimura H; Yamagiwa S; Tsuchiya A; Takamura M; Matsuda Y; Ohkoshi S; Inoue M; Wakai T; Shirai Y; Nomoto M; Aoyagi Y
    J Hepatol; 2012 Feb; 56(2):381-8. PubMed ID: 21756848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autogeneic rna-electroporated CD40-ligand activated b-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo.
    Shen S; Xu Z; Qian X; Ding Y; Yu L; Liu B
    Exp Oncol; 2007 Jun; 29(2):137-43. PubMed ID: 17704747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of CMTM6 protein in hepatocellular carcinoma involving the regulation of the immune microenvironment.
    Wei Z; Guo X; Li D; Wang J; Lin C; Tan C; Wang Y; Zhu X; Tan S
    Int J Biol Macromol; 2024 Aug; 275(Pt 2):133618. PubMed ID: 38971275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway.
    Shao Y; Lo CM; Ling CC; Liu XB; Ng KT; Chu AC; Ma YY; Li CX; Fan ST; Man K
    Cancer Lett; 2014 Dec; 355(2):264-72. PubMed ID: 25301451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
    Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
    Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
    Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma.
    Pan QZ; Pan K; Zhao JJ; Chen JG; Li JJ; Lv L; Wang DD; Zheng HX; Jiang SS; Zhang XF; Xia JC
    Cancer Immunol Immunother; 2013 Nov; 62(11):1675-85. PubMed ID: 24061617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL-mediated extrinsic signaling pathway.
    Xu S; Shu P; Zou S; Shen X; Qu Y; Zhang Y; Sun K; Zhang J
    Cancer Med; 2018 Sep; 7(9):4701-4717. PubMed ID: 30085405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous expression and regulation of CD40 in human hepatocellular carcinoma.
    Holub M; Zakeri SM; Lichtenberger C; Pammer J; Paolini P; Leifeld L; Rockenschaub S; Wolschek MF; Steger G; Willheim M; Gangl A; Reinisch W
    Eur J Gastroenterol Hepatol; 2003 Feb; 15(2):119-26. PubMed ID: 12560754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis.
    Chen S; Pu J; Bai J; Yin Y; Wu K; Wang J; Shuai X; Gao J; Tao K; Wang G; Li H
    J Exp Clin Cancer Res; 2018 Jan; 37(1):3. PubMed ID: 29316949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.
    Liu Z; Wang Y; Dou C; Sun L; Li Q; Wang L; Xu Q; Yang W; Liu Q; Tu K
    J Exp Clin Cancer Res; 2018 Mar; 37(1):49. PubMed ID: 29510736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection.
    Vanham G; Penne L; Devalck J; Kestens L; Colebunders R; Bosmans E; Thielemans K; Ceuppens JL
    Clin Exp Immunol; 1999 Aug; 117(2):335-42. PubMed ID: 10444266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours.
    Nwosu ZC; Battello N; Rothley M; Piorońska W; Sitek B; Ebert MP; Hofmann U; Sleeman J; Wölfl S; Meyer C; Megger DA; Dooley S
    J Exp Clin Cancer Res; 2018 Sep; 37(1):211. PubMed ID: 30176945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury.
    Shen X; Wang Y; Gao F; Ren F; Busuttil RW; Kupiec-Weglinski JW; Zhai Y
    Hepatology; 2009 Nov; 50(5):1537-46. PubMed ID: 19670423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.